BioPharma Credit (BPCP) Stock Chart & Stock Price History GBX 65.20 -1.10 (-1.66%) As of 11:52 AM Eastern Add Share Share Chart Stock AnalysisChartHeadlinesBuy This Stock BioPharma Credit Stock Price Performance The BioPharma Credit (BPCP) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 5.51%, with a year-to-date return of -3.87%. In the past month, the stock has decreased 0.67%, reflecting recent market activity. As of the latest close, BioPharma Credit traded at GBX 66.60 with a market cap of £915.04 million and volume of 43,273 shares. Receive BPCP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for BioPharma Credit and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-3.66%1 Month Performance-0.67%3 Month Performance-1.21%Year-To-Date Performance-3.87%1 Year Performance-5.51% BPCP Stock Chart for Thursday, September, 4, 2025 BPCP Chart by TradingView BioPharma Credit Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/03/2025GBX 67GBX 66.60-0.60%GBX 67.05GBX 66.6043,273 shs£915.04 million09/02/2025GBX 68GBX 67-1.47%GBX 67.62GBX 66.44212,633 shs£920.53 million09/01/2025GBX 67.68GBX 68+0.47%GBX 68GBX 64.2231,372 shs£1.31 billion08/29/2025GBX 67.50GBX 67.68+0.26%GBX 67.69GBX 66.4519,254 shs£1.31 billion08/28/2025GBX 66.43GBX 67.50+1.62%GBX 68.20GBX 67.5018,962 shs£1.01 billion08/27/2025GBX 67.82GBX 66.43-2.05%GBX 66.43GBX 66.436,339 shs£989.07 million08/26/2025GBX 65.50GBX 67.82+3.54%GBX 67.82GBX 66.2928,585 shs£1.01 billion08/25/2025GBX 65.50GBX 65.50GBX 68GBX 65.50229,592 shs£975.27 million08/22/2025GBX 67.40GBX 65.50-2.82%GBX 68GBX 65.50229,592 shs£975.27 million08/21/2025GBX 66.02GBX 67.40+2.09%GBX 67.40GBX 66.8927,500 shs£1.00 billion Get the Latest News and Ratings for BPCP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioPharma Credit and its competitors with MarketBeat's FREE daily newsletter. 08/20/2025GBX 65.92GBX 66.02+0.15%GBX 67.01GBX 65.6214,326 shs£983.01 million08/19/2025GBX 65GBX 65.92+1.42%GBX 65.92GBX 65.7623,440 shs£981.52 million08/18/2025GBX 65.50GBX 65-0.76%GBX 65GBX 6520,243 shs£967.82 million08/15/2025GBX 65.50GBX 65.50GBX 67.15GBX 65.5042,152 shs£975.27 million08/14/2025GBX 63.72GBX 65.50+2.80%GBX 65.55GBX 65.509,525 shs£975.27 million08/13/2025GBX 65.32GBX 63.72-2.45%GBX 66.20GBX 63.7259,054 shs£948.75 million08/12/2025GBX 63.68GBX 65.32+2.56%GBX 65.35GBX 65.32107,782 shs£972.53 million08/11/2025GBX 65.09GBX 63.68-2.16%GBX 65.35GBX 63.6868,542 shs£948.23 million08/08/2025GBX 64.60GBX 65.09+0.76%GBX 65.16GBX 65.095,172 shs£969.15 million08/07/2025GBX 65.74GBX 64.60-1.74%GBX 65.01GBX 64.6090,872 shs£961.87 million08/06/2025GBX 65.82GBX 65.74-0.11%GBX 65.80GBX 65.162,066 shs£978.89 million08/05/2025GBX 65.64GBX 65.82+0.26%GBX 65.82GBX 65.5848,690 shs£979.96 million08/04/2025GBX 65.20GBX 65.64+0.68%GBX 65.82GBX 64.1359,458 shs£977.38 million This page (LON:BPCP) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersMusk Warns. Trump Acts. Your Retirement May Depend on ItWith Donald Trump back in the White House, many believe an economic revival could be underway — but it also br...American Alternative | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThis Coin Could Explode, and it’s Hiding in Plain Sight!The #1 coin with skyrocket potential right now... Sometimes the biggest opportunities are hiding in plain s...Crypto 101 Media | SponsoredTrump’s national nightmare is hereThe headlines are shocking: Washington has taken a $10 billion stake in one of America’s biggest chipmakers — ...Porter & Company | SponsoredWall Street Legend Names #1 ‘Hidden’ AI Stock50-year Wall Street legend says to forget NVDA. For the biggest potential gains, it's time to move your money ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioPharma Credit PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share BioPharma Credit With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
